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1 |  INTRODUCTION
The assessment of muscular strength has been suggested 
as a useful indicator of functional fitness and health status, 
given its association with morbidity and mortality.1 Muscle 
strength is known to decline with age and is accompanied by 
a loss of muscle mass and increase in fat mass.2 Two studies 
have reported an association between muscular weakness and 
cancer- related mortality3,4; however, others have found no 
association.5,6 The underlying mechanisms linking strength 
preservation with better health outcomes are poorly under-
stood. Nevertheless, the association persists after adjustment 
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The specific role of different strength measures on mortality risk needs to be clarified 
to gain a better understanding of the clinical importance of different muscle groups, 
as well as to inform intervention protocols in relation to reducing early mortality. The 
aim of the systematic review and meta- analysis was to determine the relationship 
between muscular strength and risk of cancer mortality. Eligible cohort studies were 
those that examined the association between muscular strength, as assessed using 
validated tests, and cancer mortality in healthy youth and adults. The hazard ratio 
(HR) estimates obtained were pooled using random effects meta- analysis models. 
The outcome was cancer mortality assessed using the HR (Cox proportional hazards 
model). Eleven prospective studies with 1 309 413 participants were included, and 
9787 cancer- specific deaths were reported. Overall, greater handgrip (HR = 0.97, 
95% CI, 0.92- 1.02; P = .055; I2 = 18.9%) and knee extension strength (HR = 0.98, 
95% CI, 0.95- 1.00; P = .051; I2 = 60.6%) were barely significant associated with 
reduced risk of cancer mortality. Our study suggests that higher level of muscular 
strength is not statistically associated with lower risk of cancer mortality.
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for body size and does not appear to be explained by nutri-
tional status, the presence of chronic disease, or level of phys-
ical activity participation.
While a primary focus of epidemiologic investigations con-
cerning cancer mortality has been on physical activity partic-
ipation7 or cardiorespiratory fitness,8 less is known about the 
role of muscle strength preservation. Exercise- induced adap-
tations and functional preservation during cancer treatments 
may attenuate some of their negative side effects, and also 
could improve the quality of life for cancer survivors and, as 
consequence, may even increase long- term survival.9 Despite 
the known links between weak handgrip strength and all- cause 
mortality,10 only a single meta- analytic approach to date has 
been used to examine its effects (handgrip strength) on cancer 
mortality rate.11 However, what remains to be determined is 
the specific role of different strength measures on cancer mor-
tality to gain a better understanding of the clinical importance 
of different muscle groups, as well as to inform intervention 
protocols in relation to reducing early cancer mortality risk.
Therefore, the aim of this systematic review and meta- 
analysis was to synthesize the association between muscular 
strength and risk of cancer mortality.
2 |  MATERIALS AND METHODS
A systematic review and meta- analysis were conducted fol-
lowing the guidelines of the Cochrane Collaboration. Findings 
were reported according to the Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses (PRISMA).12 The 
review was registered in PROSPERO (Registration number: 
CRD42016032733).
2.1 | Data sources and searches
Two authors (AG- H and RR- V) systematically searched 
MEDLINE, EMBASE, and SPORTDiscus databases from 
their inception until 01 September 2017 (Table S1). The 
terms used were as follows(MeSH Terms): muscles OR mus-
cle strength OR muscular OR strength OR obesity OR risk 
factors AND mortality OR survival rate OR cancer mortal-
ity. Only published articles in the English language were 
included in the study. In addition, the literature search was 
supplemented through the manual review of reference list of 
selected articles.
2.2 | Eligibility criteria
The a- priori inclusion criteria are the following:
2.2.1 | Design
• Prospective cohort studies.
2.2.2 | Participants
• Healthy youth and adults excluding studies in which all pa-
tients had chronic diseases such as diabetes, heart failure, 
hypertension, peripheral artery disease, chronic obstruc-
tive pulmonary disease, cancer, and patients with critical 
illness (ie we excluded clinical studies of patient groups).
2.2.3 | Exposure
• Direct measurement of muscular strength using a validated 
strength test (eg handgrip strength test).
2.2.4 | Outcome measure
• Cancer mortality as assessed using the hazard ratio (HR—
Cox proportional hazards model).
Two authors (AG- H and RR- V) independently assessed the 
electronic search results and disagreements were resolved by 
consensus (FL). Reasons for exclusion of identified articles 
were recorded in all cases.
2.3 | Data collection process and data items
Extracted data included the first author’s name, year of publi-
cation, enrollment year, sex of the sample, duration of follow-
 up, study location, sample size, age at baseline year, HR (and 
respective 95% CIs), model covariates, muscular strength as-
sessment method, and outcome of interest and cases of can-
cer mortality. When there was insufficient information, the 
relevant corresponding author was contacted.
2.4 | Risk of bias in individual studies
An assessment of each study’s quality was made using an 
adjusted format of the Newcastle- Ottawa quality assessment 
scale.13 This scale contains 8 items categorized into 3 do-
mains (selection, comparability, and exposure). A point sys-
tem was used to enable semiquantitative assessment of study 
quality, such that the highest quality studies were awarded a 
maximum of 1 point per item with the exception of the com-
parability domain, which allowed allocating 2 points. Thus, 
the score ranged from 0 to 9 points.
2.5 | Summary measures
All analyses were carried out using STATA (version 14.0; 
STATA Corporation, College Station, TX). HRs with associ-
ated 95% confidence intervals (CIs) from studies for each out-
come of interest were extracted (used to estimate the risk of 
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mortality), and pooled HRs using random effects (DerSimonian 
and Laird) models were then calculated. The likelihood ap-
proach with random effects was used to better account for the 
inaccuracy in the estimate of between- study variance.14
2.6 | Synthesis of results
The percentage of total variation across the studies due to 
heterogeneity (Cochran’s Q- statistic)15 was used to calculate 
the I2 statistics, considering I2 values of <25%, 25%- 50%, 
and >50% as small, medium, and large amounts of heteroge-
neity, respectively.16 Influence analyses were conducted to 
assess the robustness of the summary estimates to determine 
whether any individual study accounted for the heterogene-
ity. Thus, each study was deleted from the model once to 
analyze the influence of each study on the overall results.
2.7 | Risk of bias across studies
Small- study effects bias was assessed using the extended 
Egger’s test,17 and the presence of publication bias was in-
vestigated graphically by examining funnel plots.
2.8 | Subgroup analysis
Subgroup moderator analyses were conducted to determine 
whether muscular strength differed according to sex or type 
of muscular strength assessment test, by stratifying meta- 
analyses by each of these factors. Therefore, we performed 
a meta- analysis by subgroups as defined with each measure-
ment criterion. Also, random effects meta- regression analy-
ses were used to separately evaluate whether results were 
different by mean age of participants at baseline.18 A P- value 
<.05 was considered statistically significant.
3 |  RESULTS
3.1 | Study selection
The electronic search strategy retrieved 1126 articles. 
After removing duplicate references and studies which do 
not meet inclusion criteria, only 13 articles were screened 
for eligibility based on title and abstract. The reason for 
exclusion based on full- text review was due to duplicate 
data  (1 study)4,19 or analysis used (non- Cox proportional 
hazards model).5 Finally, 11 original prospective cohort 
studies met our inclusion criteria and were included in the 
meta- analysis (Figure S1).
3.2 | Study characteristics
Table S2 summarizes the characteristics of the eleven included 
studies.3,19-27 All of them were prospective observational 
studies, and were published from 2007 to 2017. The eleven 
studies included a total of 1 309 413 participants. Sample sizes 
ranged from 60024 to 1 142 599 participants.22 All studies re-
ported a combined 9787 cancer- specific deaths. The age at co-
hort enrollment ranged from 1622 to 80 years.23 Studies were 
conducted in the United States,19,28 Sweden,22 Japan,20,23,24,26 
Norway,25,27 and 17 high- income, middle- income, and low- 
income countries.21 The follow- up duration ranged from 
4 years23 to 24.2 years.22
3.3 | Muscle strength tests
Eight studies assessed the muscular strength using the hand-
grip test.20-27 The assessment consisted of 3 attempts with 
dominant21,25 or nondominant hand25, 2 attempts (dominant 
hand)23,24,26,27 and averaging both hands.20,21,23,24 The high-
est20,23,24,26,27 or mean21,25 value was used for the analyses 
expressed as kilograms.
In the remaining studies, muscular strength was as-
sessed using a variety of test protocols. Four studies 
used a dynamometer to assess isokinetic knee extension 
strength.23,24,28 One study22 assessed knee extension, 
handgrip, and elbow flexion strength. Ruiz et al19 assessed 
upper body strength with a one repetition maximum supine 
bench press, and lower body strength with a one repetition 
maximum seated leg press. Low and high muscular strength 
were determined using each study’s population distribution 
(ie quartiles, quintiles). All the studies except one adjusted 
the estimates by age, tobacco use,20 or body mass index,22 
respectively.
3.4 | Risk of bias within studies
All studies met at least 7 of the Newcastle- Ottawa quality 
assessment criteria except one3 and were considered to have 
adequate methodological quality. The studies’ score ranged 
from 8 to 9, with a mean total score of 8.7 (Table S3).
3.5 | Meta- analysis
Figure 1 depicts the pooled HR forest plot of low (reference) 
versus high muscular strength based on the handgrip strength 
assessment. The pooled HR of cancer mortality via handgrip 
strength test was 0.97 (95% CI, 0.92- 1.02; P = .055), with 
low heterogeneity (I2 = 18.9%; Figure 1). When we analyzed 
cancer mortality risk in relation to knee extension strength, 
the pooled HR was 0.98 (95% CI, 0.95- 1.00; P = .051; 
I2 = 60.6%; Figure 2).
Meta- regression analyses plotting age mean shows that 
there were no observed significant effects on the HR esti-
mates (P = .101 and P = .982, for handgrip and knee exten-
sion, respectively).
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F I G U R E  1  Forest plot showing the hazard ratios of cancer mortality comparing low (reference) versus high handgrip strength
F I G U R E  2  Forest plot showing the hazard ratios of cancer mortality comparing low (reference) versus high knee extension strength
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3.6 | Publication bias and sensitivity analysis
When the impact of individual studies was examined by re-
moving studies from the analysis one at a time, we observed 
that the pooled HR estimate for low muscular strength re-
mained unchanged. There was no indication of study bias 
(Egger test; P = .257 and P = .121, for handgrip and knee 
extension, respectively). Also, the funnel plot for the rela-
tionships of handgrip strength with cancer mortality was not 
asymmetric, thus indicating no issues of bias (Figure S2). We 
have not included a funnel plot for knee extension strength 
due to should be used only when there are at least 10 studies 
included in the meta- analysis.
4 |  DISCUSSION
Our meta- analysis shows that low muscular strength is barely 
significant associated with the risk of cancer mortality. Also, 
the age at baseline was not significant moderator of muscu-
lar strength on cancer mortality; however, there was a trend 
(muscular strength is less protective in older individuals). It 
is necessary to take into consideration that the prospective 
design of the study not allow to know whether improved 
muscle strength prevents cancer development or improves 
survival with cancer.
To date, few studies have examined the association be-
tween muscular strength and cancer mortality and findings 
have been inconsistent. Our meta- analysis included eleven 
prospective cohort studies and most reported no significant 
association between muscular strength and cancer mortal-
ity, except for 3 studies.3,19,28 In a national cohort of people 
aged 65 and older from the United Kingdom, Gale et al3 
showed that weaker handgrip strength (per SD increase in 
grip strength) predicted increased cancer mortality in men 
(HR = 0.81, 95% CI 0.70- 0.95), but not in women. In that 
study, the authors hypothesized that the influence of mus-
cular strength on survival may be more closely related with 
the muscle functional status in men rather than with muscle 
size. Similarly, Sasaki and colleagues6 found that stronger 
handgrip was associated with lower cancer mortality, but 
only in men. The PURE study included 139 691 men and 
women aged 35- 70 years old from 17 different countries 
and reported and inverse correlation between high grip 
strength and low cancer mortality only in high- income 
countries, not in middle- and low- income countries.21 
Meanwhile, another study included young Swedish men 
aged 16- 19 years; they followed up for 24 years indicating 
that the oldest subjects were 43 years old at the time of 
analyses and thus probably too young for analyzing the risk 
of cancer mortality.22
However, the pooled data included in our meta- analysis 
that used handgrip testing to assess muscle strength showed 
barely significant association with cancer mortality. The fact 
that these studies only assessed muscular strength in small 
muscle groups (ie forearms) may have masked the association 
between strength and morality. Although handgrip strength 
has a moderate- to- high correlation with total muscle strength, 
particularly in youth and young adults,29 the correlation be-
tween handgrip strength and strength in larger muscle groups 
(eg low- body muscle) is less robust among older adults.30 It 
is also possible that obesity may have confounded our results, 
as greater body mass is highly associated with grip strength. 
Indeed, previous studies have demonstrated the role of higher 
body mass adjusted handgrip strength as a predictive factor 
for reduced cardiometabolic diseases and disability,31 as well 
as early mortality.32
Findings from 2 studies19,28 indicate that muscular 
strength measurements should represent musculature in-
volved with activities of daily living, such as getting up, 
lifting, or carrying things. In a prospective cohort of 
8677 men, aged 20- 82 years, Ruiz and colleges19 reported 
that higher levels of muscular strength, assessed with an 
index combining 1- repetition maximal measures for leg 
and bench press, are associated with lower cancer mortal-
ity risk. Surprisingly, a recent study published by Dankel 
et al28 using the 1999- 2002 NHANES data also suggested 
that individuals in the upper quartile for knee extension 
muscle were at a 50% reduced risk; however, the limited 
number of deaths due to cancer (n = 160) favors high dis-
persion in the results (HR = 0.50, 95% CI 0.29- 0.85) and 
increased heterogeneity in our pooled results. Given that 
specific cancer types have distinct etiologies, the biologic 
pathways through which low muscular strength influence 
risk of one type of cancer may differ from the pathogenesis 
and disease progression of other cancers.33 Therefore, more 
studies are needed to better understand the role of muscle 
strength preservation, and resistance exercise interventions 
for treatment by cancer subtypes.
A primary strength of our study is that we included data 
from large populations, including high- quality prospective 
studies with a mean follow- up >10 years (mean 12.8 years), 
representing various countries, ethnic origins, and socio- 
economic backgrounds. However, there are some limita-
tions that should be considered when interpreting these 
results. First, although all of the included studies had pro-
spective follow- up designs, they are not free of the inherent 
limitations for cohort studies, which ultimately prevented 
us from making definitive conclusions about the causal role 
of muscular strength in cancer mortality. Second, although 
potential confounders were controlled for in all studies, we 
cannot exclude the possibility that residual confounding 
underlies the association between strength and cancer mor-
tality. Indeed, we were unable to determine whether other 
competing risks or unmeasured confounding (ie other life-
style risk factors, comorbidities, or socio- economic status) 
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may have influenced the observed association of muscu-
lar strength with death.32 Third, due to a lack of available 
data, we were unable to calculate cancer- specific summary 
measures of association. Fourth, due to the wide follow- up 
duration range of 4- 24.2 years, and the fact that muscle 
strength does not remain stable over time, this variability 
in follow- up could certainly influence the effect of base-
line strength on cancer mortality. Finally, the categoriza-
tion of muscular strength in the studies was heterogeneous 
and may have led to overestimation of the reported asso-
ciations; also differences in sex distribution and/or cancer 
type among studies may be behind discrepancies regarding 
cancer mortality.
In summary, our study demonstrated that higher level 
of muscular strength was barely significant associated with 
lower risk of cancer mortality. Also, these results should be 
cautiously interpreted because some potential heterogeneity- 
related concerns limit their generalizability. Further studies 
are needed to identify a plausible biological link between 
strength preservation and the risk of dying from cancer, as 
well as to determine the extent to which resistance exercise 
may benefit specific cancer subtypes.
5 |  PERSPECTIVE
Previous meta- analyses have reported that muscle strength 
is a predictor of all- cause mortality10 and cardiovascular dis-
ease mortality11 in community- dwelling populations. The 
current study reported that higher level of muscular strength 
was barely significant associated with lower risk of cancer 
mortality. The mechanisms that muscular strength is strongly 
associated with all- cause and cardiovascular disease mortal-
ity and slightly with cancer mortality need to be explored in 
further studies. Despite the lack of associations in the present 
study, muscular strength could be easily and universally ap-
plied to identify frail people at increased risk of premature 
cancer mortality.
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